Manifold Bio is a pioneering platform therapeutics company that has built the first high-throughput in vivo (HTV) discovery engine. This engine combines massively multiplexed in vivo screening and AI-powered design to accelerate the development of tissue-targeted medicines.
- Category
- Drug Discovery & Development
- Stage
- Series A
- Employees
- 59
- HQ
- Boston, United States
- Founded
- 2019
- Funding
- $78M